Evista

Evista-uk

Active substance: Raloxifene

Dosage: 60 mg

Price: €40.85 – €299.03

Calcium loss is the main cause of osteoporosis in old age. With this condition, fractures occur even with minimal exposure. Don’t you want to experience all the “charms” of this condition? Evista is your best friend in the fight for healthy bones. Many women in United Kingdom rely on Evista for healthy bones. Why is that? In this article we tell you why. And if Evista has long been an indispensable inhabitant of your medicine cabinet, it’s time to replenish the stock. We advise you to buy it from our online pharmacy, because who would refuse perfect service, the best prices, fast delivery and the possibility to order a medicine without presenting a prescription?

What is Evista

Evista is a medicine containing the substance raloxifene. This medicine is used to treat and prevent osteoporosis in postmenopausal women. It helps to strengthen bones, reduce the risk of fractures, and reduce the risk of breast cancer.

Indications For Use

The drug is prescribed to postmenopausal women with low bone density and high risk of fractures.

Contraindications For Use

The drug has a number of well-defined contraindications for use, such as hypersensitivity to raloxifene or other substances contained in the drug, hepatic dysfunction including cholestasis, venous thrombosis, severe renal insufficiency, uterine bleeding of unknown aetiology, endometrial cancer, pregnancy and lactation, prolonged immobilisation.
The drug should not be administered to women of childbearing age.

Side effects

Some side effects that may occur when using Evista are dizziness, headache, nausea and abdominal pain. In rare cases, serious side effects such as thrombosis and endometrial cancer may occur. Therefore, you should discuss all risks and side effects with your doctor before you start using the medicine.

Methods of Use and Dosage

The medicine is taken orally, with or without food, once a day with plenty of water. The doctor prescribes the dosage and duration of treatment depending on the individual patient and the degree of osteoporosis. The recommended dose is usually 60 mg per day.